Posted Tue, Sep, 03,2013
Published today in Clinical Medicine Insights: Endocrinology and Diabetes is a new review by Chitrabhanu Ballav and Stephen C.L. Gough. Read more about this paper below:
Title
Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
Abstract
The biguanide, metformin, is considered first-line treatment for type 2 diabetes. Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor acts through the incretin pathway and has a glucose dependent mode of action. The complementary hypoglycemic properties of these drugs make fixed dose combination treatment an attractive prospect. Evidence from recent clinical trials suggests a beneficial effect of the combination on efficacy, demonstrated by significant improvement of hemoglobin A1c (HbA1c), fasting and postprandial glucose levels. The fixed dose combination is likely to have greater patient tolerability compared with monotherapy with either agent because of low rates of hypoglycemia, weight neutrality, and lower rates of side effects. High acquisition cost and paucity of long-term safety data are, however, potential barriers to their wider use. An overview of the pharmacology and clinical outcomes from recent trials of the metformin-sitagliptin combination and how the combination could fit into the type 2 diabetes treatment algorithm is presented in this review.
Click here to learn more about the article, download it and comment
Posted in: Articles Published
News Categories
Thu 08 Oct, 2015
Published This Week (5th - 9th October)Thu 08 Oct, 2015
Biomarker Insights Paper Endorsed by Editor in ChiefWed 07 Oct, 2015
Interview with Professor Jamie DaviesRecently we published a paper describing cloning of a new kinase gene, MLK4, in Genomics Insights.I was impressed by the prompt processing and speed of publication. The comments from the reviewers allowed me to improve the paper significantly. The reviews were scientifically deep and objective, which is very valuable because in many journals decisions to publish or not to publish are very unfair and subjective. I highly recommend that other researchers publish their papers in ...
Facebook Google+ Twitter
Pinterest Tumblr YouTube